Trial updateGlaucoma
Single-site Pilot Study Evaluating the Effect of QLS-111 Ophthalmic Solution on Posterior Perfusion and Vessel Dilation
Active, not recruiting. Phase 2. Registered enrolment: 14. Qlaris Bio, Inc.
Why it matters
Track this study through NCT07354477. No results are posted in this registry record.
The study at a glance
- Registry status
- Active, not recruiting
- Phase
- Phase 2
- Registered enrolment
- 14
- Results posted
- No
- Sponsor
- Qlaris Bio, Inc.
Keep in mind
Registry information describes the study; recruitment status alone does not establish efficacy or safety.